Insulin-like Growth Factor-1 Levels Reflect Muscle and Bone Health and Determine Complications and Mortality in
Parminder Kaur1, Nipun Verma1, Aishani Wadhawan1
1Postgraduate Institute of Medical Education and Research, Sector 12, Chandigarh, India.
Insights
Reduced insulin-like growth factor 1 (IGF-1) levels in cirrhosis patients are linked to sarcopenia, frailty, and poor outcomes. Lower IGF-1 indicates higher complication risk and mortality, but increases suggest better survival.
Area of Science:
- Endocrinology
- Hepatology
- Geriatrics
Background:
- The growth hormone-insulin-like growth factor (GH-IGF-1) axis is crucial but its role in cirrhosis complications like sarcopenia, frailty, and bone health is unclear.
- Understanding GH-IGF-1 axis impairment is vital for managing cirrhosis prognosis.
Purpose of the Study:
- To investigate the association between serum GH and IGF-1 levels and clinical outcomes in adult decompensated cirrhosis outpatients.
- To determine the predictive value of IGF-1 for complications and 180-day mortality in cirrhosis.
Main Methods:
- Serum GH and IGF-1 levels were measured in 172 adult decompensated cirrhosis outpatients.
- Associations were analyzed with sarcopenia (CT-SMI), liver frailty index (LFI), osteodystrophy (DEXA), clinical decompensations, and 180-day survival.
- The predictive accuracy of IGF-1 for mortality was compared with MELD-Na scores.
Main Results:
- Lower IGF-1 levels correlated with sarcopenia, osteodystrophy, higher LFI, CTP, and MELD-Na scores (P < 0.05).
- Patients with low IGF-1 had increased overall complications, ascites, and encephalopathy (P < 0.05).
- IGF-1 and MELD scores independently predicted 180-day mortality, with combined IGF-1 and MELD-Na improving prediction accuracy (AUC 0.729).
Conclusions:
- Reduced IGF-1 levels are a marker for sarcopenia, frailty, and osteodystrophy in cirrhosis.
- Low IGF-1 is associated with increased disease severity, complications, and mortality in cirrhosis patients.
- Increasing IGF-1 levels during follow-up correlate with improved survival and reduced complications.
Background:
The growth hormone-insulin-like growth factor (GH-IGF-1) axis and its impairment with sarcopenia, frailty, bone health, complications, and prognosis are not well characterized in cirrhosis.
Methods:
We investigated the adult decompensated cirrhosis out-patients at a tertiary care institute between 2021 and 2023 for serum GH and IGF-1 levels, and associated them with sarcopenia (CT-SMI in cm2/m2), liver frailty index (LFI), osteodystrophy (DEXA), clinical decompensations (overall, ascites, encephalopathy, infection, and bleed), and survival up to 180 days.
Results:
One-hundred-seventy-two patients, 95% males, aged 46.5 years (median). logIGF-1 levels were negatively associated with sarcopenia, osteodystrophy, LFI, CTP, and MELD-Na score (P < 0.05 each). Patients with low IGF-1 levels had a higher incidence of complications (overall, ascites and encephalopathy) than those with intermediate, and high IGF-1 levels (P < 0.05 each). Both logIGF-1 (AUC: 0.686) and MELD (AUC: 0.690) could predict 180-day mortality (P < 0.05, each). Adding logIGF-1 with MELDNa further improved discriminative accuracy of MELDNa (AUC: 0.729) P < 0.001. The increase in IGF-1 on follow-up was associated with better survival and fewer complications.
Conclusion:
Reduced IGF-1 levels reflect sarcopenia, frailty, and osteodystrophy in cirrhosis. Low IGF-1 are associated with severity, development of decompensations, and mortality.
More Related Videos
08:03Treatment of Ligament Constructs with Exercise-conditioned Serum: A Translational Tissue Engineering Model
Published on: June 11, 2017
08:04Isolation of Primary Mouse Hepatocytes for Nascent Protein Synthesis Analysis by Non-radioactive L-azidohomoalanine Labeling Method
Published on: October 23, 2018
Related Concept Videos
Hormones and Bone Tissue
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones Regulating Blood Glucose
In addition to accelerating glucose uptake and utilization, insulin has...
Liver Physiology
Metabolic Regulation:
The liver is the central organ involved in regulating blood composition. It stabilizes blood glucose levels, maintaining them within the range of 70–110 mg/dL. When these levels drop, the liver breaks down glycogen reserves and releases glucose into the bloodstream. It can...
Insulin: Dosing Regimen and Adverse Effects
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...
Hypoglycemia and Glucagon
Liver Regeneration
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are...
